Register for free to listen to this article
Listen with Speechify
0:00
2:00
HUNTINGDON, U.K.—Envigo announced in fall 2016 the launch of a dedicated Science and Technology Advisory Group (STAG) to drive forward emerging areas of research and to collaborate with customers to develop new technologies. The STAG group will run across all service offerings of Envigo, including pharmaceutical development, research models and services, as well as crop protection and chemicals testing.
 
The key goal behind the new group is to advance Envigo’s commitment to developing the next generation of research services, technology and science. As such, the group will sponsor internal programs designed to develop new or improve existing capabilities. Selected external partnerships will also be explored—including collaborations with academia through postdoctoral sponsorship, placement and combined research—along with offering science and technology development services to customers.
 
Brian Burlinson, deputy chair of the STAG, commented: “We are encouraging our scientists to put forward new projects for funding, acting as an internal innovation incubator, but also, we are going out to market and asking our customers if they have research problems they would like us to develop into commercial solutions. However, it’s not just about today’s problems, as we are also partnering with universities, both on developing new science and offering work placements to graduates ... our ethos is to instill a culture of new science that permeates all areas of the business.”
 
Another central goal of STAG is to work closely with Envigo’s customers to develop new screening assays, utilizing the company’s advanced science and technology to meet ongoing R&D demands.
 
Beyond customer contracts, the group is also planning to independently develop new assays and technologies that Envigo can potentially sell to customers in the future.
 
The STAG will have a core membership of six to eight representatives for the first three years from a range of technical disciplines across the company. However, after this period the STAG committee membership will rotate on two-year cycles to ensure a regular impetus of new ideas and thinking.

Related Topics

Published In

Volume 13 - Issue 1 | January 2017

January 2017

January 2017 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue